Buy Abbott: defensive compounder with recurring cash flow. Libre diabetes devices drive growth; 2025 guidance reaffirmed.

LGA, a CPA and business advisory company in New England, USA, has announced its merger with accounting business Abbott & Company. Abbott & Company, led by Mellinda Abbott, offers personalised ...

Baby formula maker Abbott Nutrition said Saturday that it is restarting production at its Michigan plant after meeting requirements from the FDA. The plant shut down in February after FDA inspectors ...

Abbott is a well-diversified healthcare company with strong underlying revenue growth and a robust product pipeline. The company's business lines are well-diversified, with direct consumer sales and ...

Over the past six months, Abbott Laboratories’s shares (currently trading at $125.45) have posted a disappointing 7.9% loss, ...

Abbott recently released its 2022 Global Sustainability Report, highlighting efforts to help the greatest number of people live better, healthier lives Abbott recently released its 2022 Global ...

Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.

In his 20 th year as chief executive of Abbott Laboratories, Miles White appears to have settled on his successor at the diversified healthcare company. The 63-year-old White this week named long-time ...

Diabetes and obesity treatments including Ozempic, Wegovy, and Mounjaro are experiencing extraordinary demand. One unintended consequence of losing weight can be shedding muscle mass, which can be ...

Abbott Laboratories is making a $5.8 billion investment in rapid diagnostic testing, a sign of how testing is moving closer to patients and away from centralized labs. The Abbott Park-based company ...

- Strategic action will propel Abbott to No. 1 position with annual sales growth approaching 20 percent in India, expected to exceed $2.5 billion in sales by 2020 - Piramal's comprehensive portfolio ...

Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here. After the Food and Drug Administration said last week that it is investigating preliminary data suggesting ...